Results 111 to 120 of about 27,127 (159)

Multiple Myeloma and AL Amyloidosis [PDF]

open access: yes, 2016
O mieloma múltiplo e a amiloidose de cadeias leves (AL) de imunoglobulina são doenças proliferativas plasmocitárias incuráveis que raramente coexistem. Cerca de 10 a 15% dos doentes com mieloma múltiplo desenvolvem amiloidose AL clinicamente sintomática,
Alcatrão, M   +5 more
core  

Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy. [PDF]

open access: yes, 2017
BACKGROUND: Severe left ventricular (LV) systolic dysfunction is an uncommon complication of hypertrophic cardiomyopathy (HCM) that is associated with poor prognosis.
Biagini   +22 more
core   +2 more sources

Two cases of monoclonal nodular pulmonary amyloidosis and review of the literature [PDF]

open access: yes, 2016
Nodular pulmonary amyloidosis (NPA) is an uncommon pathology of insoluble protein depositing in pulmonary parenchyma. This localized pulmonary form of amyloidosis is most often found to contain combinations of kappa and lambda immunoglobulin light chain ...
Endicott, Kendal   +4 more
core   +2 more sources

Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis

open access: yesBlood Cancer Journal, 2023
Rajshekhar Chakraborty   +5 more
semanticscholar   +1 more source

Immunoglobulin Light-Chain Amyloidosis: Clinical Presentations and Diagnostic Approach

open access: yesJournal of the Advanced Practitioner in Oncology, 2019
Systemic immunoglobulin light-chain (AL) amyloidosis is a rare disorder arising from a plasma cell clone that produces misfolded immunoglobulin light chains, which are deposited in various tissues and organs as amyloid fibrils.
Y. Hwa   +6 more
semanticscholar   +1 more source

A simple voltage/mass index increases the suspicion of amyloidotic cardiomyopathy: an electrocardiographic and echocardiographic study of 767 patients with increased left ventricular wall thickness due to different causes [PDF]

open access: yes, 2015
Background-Amyloidotic cardiomyopathy (AC) can mimic true left ventricular hypertrophy (LVH), including hypertrophic cardiomyopathy (HCM) and hypertensive heart disease (HHD).
Quarta, Candida Cristina <1981>
core   +1 more source

A risk stratification for systemic immunoglobulin light‐chain amyloidosis with renal involvement

open access: yesBritish Journal of Haematology, 2019
Renal involvement is found in about 70% of patients with systemic immunoglobulin light‐chain (AL) amyloidosis. However, there is no risk stratification system specialized for renal AL concerning patients’ survival. Galectin‐3 (Gal‐3) has been reported to
Ting Li   +10 more
semanticscholar   +1 more source

Urinary Biomarkers for Kidney Disease in ATTR Amyloidosis [PDF]

open access: yes, 2014
Aim: The detection and prognosis of nephropathy in transthyretin amyloidosis depends on albuminuria and renal function. Knowing that urinary levels of alpha-1 microglobulin and beta-2 microglobulin reflect tubular dysfunction while urinary alpha-2 ...
Beirão, I.   +5 more
core   +1 more source

Pharmacological stabilization of the native state of full-length immunoglobulin light chains to treat light chain amyloidosis.

open access: yesCurrent Opinion in Chemical Biology, 2023
N. Yan   +4 more
semanticscholar   +1 more source

Current management of non‐amyloidosis monoclonal gammopathy of renal significance: Clinical features, treatment selections, responses and renal outcomes

open access: yes
British Journal of Haematology, Volume 208, Issue 1, Page 329-332, January 2026.
Daniel Cancilla   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy